Ellington Management Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-13,100
| Closed | -$252K | – | 807 |
|
|
2017
Q1 | $252K | Buy |
+13,100
| New | +$252K | 0.01% | 501 |
|
|
2015
Q4 | – | Sell |
-7,800
| Closed | -$292K | – | 729 |
|
|
2015
Q3 | $292K | Buy |
+7,800
| New | +$292K | 0.08% | 422 |
|
|
2014
Q1 | – | Sell |
-17,200
| Closed | -$361K | – | 716 |
|
|
2013
Q4 | $361K | Sell |
17,200
-18,800
| -52% | -$395K | 0.13% | 262 |
|
|
2013
Q3 | $846K | Buy |
36,000
+1,800
| +5% | +$42.3K | 0.16% | 152 |
|
|
2013
Q2 | $919K | Buy |
+34,200
| New | +$919K | 0.17% | 127 |
|